Related Experiment Videos
Immune responses to plasmid DNA encoding the hepatitis C virus core protein
1Division of Infectious Diseases and Immunology, Saint Louis University Health Sciences Center, MO 63104, USA.
Journal of Virology
|September 1, 1995
Summary
This study explored a DNA vaccine for Hepatitis C virus (HCV) using the core protein. The vaccine candidate elicited significant immune responses in mice, suggesting its potential for HCV prevention.
Area of Science:
- Virology
- Immunology
- Vaccine Development
Background:
- Hepatitis C virus (HCV) is a primary cause of non-A, non-B hepatitis transmitted parenterally.
- The core protein-encoding region of HCV shows relative conservation across strains.
Purpose of the Study:
- To develop a DNA vaccine expressing the Hepatitis C virus core protein.
- To assess the immunogenicity of a DNA vaccine encoding the HCV core protein in a mouse model.
Main Methods:
- Amplification and cloning of the HCV core protein gene (amino acids 1-191, HCV-1 strain) into an eukaryotic expression vector.
- Intramuscular inoculation of the recombinant plasmid DNA into BALB/c mice.
- Evaluation of immune responses, including antibody, lymphoproliferative, and cytotoxic T-lymphocyte (CTL) activity.
Main Results:
- Successful generation of a DNA vaccine construct expressing the HCV core protein.
- Induction of core-specific antibody responses in inoculated mice.
- Demonstration of lymphoproliferative and cytotoxic T-lymphocyte activity following vaccination.
Conclusions:
- The developed DNA vaccine candidate expressing the HCV core protein elicits robust cellular and humoral immune responses.
- The findings support further investigation of this HCV core polynucleotide as a potential vaccine against Hepatitis C virus infection.